bed in the Company's annual report on Form 10-K for the yearended December 31 2007 the Company's quarterly report on Form 10-Q forthe three months ended March 31 2008 as well as other filings with theSecurities and Exchange Commission. You are cautioned not to place unduereliance on these forward-looking statements which speak only as of thedate hereof. This caution is made under the saf
Date:6/30/2008
bed in the Company's annual report on Form 10-K for the year
ended December 31, 2007, the Company's quarterly report on Form 10-Q for
the three months ended March 31, 2008, as well as other filings with the
Securities and Exchange Commission. You are cautioned not to place undue
reliance on these forward-looking statements, which speak only as of the
date hereof. This caution is made under the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. All forward-looking
statements are qualified in their entirety by this cautionary statement and
SGX undertakes no obligation to revise or update this press release to
reflect events or circumstances after the date hereof.
'/>"/>SOURCE SGX Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
VIA Pharmaceuticals Set to Join Russell Microcap Index2.
Wyeth Pharmaceuticals Announces Organizational Change3.
Access Pharmaceuticals Presents New Data at International Symposium Showing Companys Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells4.
Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference5.
Portola Pharmaceuticals Names William Lis Vice President of Business Development and Commercial Operations6.
Stason Pharmaceuticals, Inc. Appoints Diana Wood as Vice President, Business Development7.
Brian Levy, OD, MSc, Named Chief Operating Officer of Danube Pharmaceuticals8.
Raptor Pharmaceuticals Corp. Announces Presentation at 5th International Cystinosis Conference 20089.
Onyx Pharmaceuticals to Present at Jefferies 2nd Annual Healthcare Conference10.
Sunesis Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference11.
Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China